168 related articles for article (PubMed ID: 1888745)
1. Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.
Patston PA; Gettins P; Beechem J; Schapira M
Biochemistry; 1991 Sep; 30(36):8876-82. PubMed ID: 1888745
[TBL] [Abstract][Full Text] [Related]
2. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
[TBL] [Abstract][Full Text] [Related]
3. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
[TBL] [Abstract][Full Text] [Related]
4. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy.
Perkins SJ; Smith KF; Nealis AS; Haris PI; Chapman D; Bauer CJ; Harrison RA
J Mol Biol; 1992 Dec; 228(4):1235-54. PubMed ID: 1335516
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure and molecular modelling of C1- inhibitor.
Perkins SJ
Behring Inst Mitt; 1993 Dec; (93):63-80. PubMed ID: 8172587
[TBL] [Abstract][Full Text] [Related]
7. Regulation of C1-inhibitor function by binding to type IV collagen and heparin.
Patston PA; Schapira M
Biochem Biophys Res Commun; 1997 Jan; 230(3):597-601. PubMed ID: 9015369
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the serpin domain of C1 inhibitor.
Coutinho M; Aulak KS; Davis AE
J Immunol; 1994 Oct; 153(8):3648-54. PubMed ID: 7930585
[TBL] [Abstract][Full Text] [Related]
10. The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant.
Bos IG; Lubbers YT; Roem D; Abrahams JP; Hack CE; Eldering E
J Biol Chem; 2003 Aug; 278(32):29463-70. PubMed ID: 12773530
[TBL] [Abstract][Full Text] [Related]
11. C1-inhibitor-serine proteinase complexes and the biosynthesis of C1-inhibitor by Hep G2 and U 937 cells.
Patston PA; Medcalf RL; Kourteva Y; Schapira M
Blood; 1993 Dec; 82(11):3371-9. PubMed ID: 8241507
[TBL] [Abstract][Full Text] [Related]
12. The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism.
Brown EW; Ravindran S; Patston PA
Blood Coagul Fibrinolysis; 2002 Dec; 13(8):711-4. PubMed ID: 12441910
[TBL] [Abstract][Full Text] [Related]
13. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
Schapira M; Scott CF; Colman RW
Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
[TBL] [Abstract][Full Text] [Related]
14. Structure and function of C1 inhibitor.
Davis AE
Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
[TBL] [Abstract][Full Text] [Related]
15. Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass.
Wachtfogel YT; Harpel PC; Edmunds LH; Colman RW
Blood; 1989 Feb; 73(2):468-71. PubMed ID: 2917186
[TBL] [Abstract][Full Text] [Related]
16. Role of the distal hinge region of C1-inhibitor in the regulation of C1s activity.
He S; Yang JC; Tsang S; Sim RB; Whaley K
FEBS Lett; 1997 Aug; 412(3):506-10. PubMed ID: 9276455
[TBL] [Abstract][Full Text] [Related]
17. Effect of reactive site loop elongation on the inhibitory activity of C1-inhibitor.
Bos IG; Lubbers YT; Eldering E; Abrahams JP; Hack CE
Biochim Biophys Acta; 2004 Jun; 1699(1-2):139-44. PubMed ID: 15158721
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitor.
Drouet C; Bouillet L; Csopaki F; Colomb MG
FEBS Lett; 1999 Sep; 458(3):415-8. PubMed ID: 10570951
[TBL] [Abstract][Full Text] [Related]
19. The native metastable fold of C1-inhibitor is stabilized by disulfide bonds.
Simonovic I; Patston PA
Biochim Biophys Acta; 2000 Aug; 1481(1):97-102. PubMed ID: 11004579
[TBL] [Abstract][Full Text] [Related]
20. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion.
Cai S; Davis AE
J Immunol; 2003 Nov; 171(9):4786-91. PubMed ID: 14568956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
